SHAKILYA KHALIF: Open Payments
NPI 1013335884 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,431 in 59 payments from 18 companies in 2025. Trend: 2023 $1,296 · 2024 $1,649 · 2025 $1,431
Food & beverage: $1,431
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $273 |
| Lilly USA, LLC | 12 | $175 |
| AstraZeneca Pharmaceuticals LP | 6 | $156 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $104 |
| SANOFI-AVENTIS U.S. LLC | 1 | $104 |
| Exact Sciences Corporation | 5 | $92 |
| Otsuka America Pharmaceutical, Inc. | 3 | $90 |
| PFIZER INC. | 3 | $69 |
| Amgen Inc. | 4 | $62 |
| BETA BIONICS, INC. | 2 | $55 |
Products named: MOUNJARO, Ozempic, FARXIGA, Kerendia, TZIELD, Cologuard Collection Kit, REXULTI, NURTEC ODT.
Industry payments across SC — which companies pay providers there.
